Should Premenstrual Syndrome Be a Legal Defense?

  • Katharina Dalton


Before premenstrual syndrome (PMS) can be accepted as a basis for a legal defense, three conditions need to be fulfilled. First, the narrow definition must be recognized, understood, and followed. Second, it must be shown that treatment has diminished the occurrence of criminal acts. Third, effective treatment must be freely available and implemented with adequate supervision to ensure that criminal acts are not repeated during successive premenstra.


Luteinizing Hormone Follicle Stimulate Hormone Luteal Phase Postnatal Depression Luteinizing Hormone Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Backstrom, T. L., L. Wide, R. Sodergard, and H. Cartensen, 1976. FSH, LH, TeBg capacity, estrogen and progesterone in women with premenstrual tension in the luteal phase.Journal of Steroid Biochemistry 7: 473–476.PubMedCrossRefGoogle Scholar
  2. Clare, A. W., 1982. Psychiatric and social aspects of premenstrual complaint.Psychological Medicine (Monograph Supplement) 4: 1–58.CrossRefGoogle Scholar
  3. Dalton, K., 1955. Discussion on the Premenstrual Syndrome.Proceedings of the Royal Society of Medicine 60: 415–417.Google Scholar
  4. Dalton, K., 1980. Cyclical criminal acts in premenstrual syndrome.The Lancet 2: 1070–1071.CrossRefGoogle Scholar
  5. Dalton, K., 1982a. Legal implications of PMS.World Medicine,April 17, pp. 93–94.Google Scholar
  6. Dalton,K., 1982b. An overview premenstrual tension. In: R. Friedman (Ed.),Menstruation and Behaviour. Marcel Dekker, New York, Chapter 11.Google Scholar
  7. Dalton, K., 1984.Premenstrual Syndrome and Progesterone Therapy(second edition). Year Book Publishers, Chicago; and William Heinemann Medical Books, London.Google Scholar
  8. Dalton, K., 1985. Progesterone prophylaxis used successfully in Postnatal Depression.The Practitioner 229: 507–508.Google Scholar
  9. Dalton, M. E., 1981. Sex hormone binding globulin binding capacity in women with severe premenstrual syndrome.Postgraduate Medical Journal 67: 560–561.CrossRefGoogle Scholar
  10. Dalton, M. E., 1984a. The effect of progesterone administration on sex hormone binding capacity in women with severe premenstrual syndrome.Journal of Steroid Biochemistry 20: 437–439.PubMedCrossRefGoogle Scholar
  11. Dalton, M. E., 1984b. The diagnostic value of sex hormone binding globulin in women with premenstrual syndrome. Paper presented at the 15th International Congress of the International Society for Psychoneuroendocrinology, Vienna, June.Google Scholar
  12. Dalton, M. E., 1985. Nasal absorption of progesterone. Paper presented at the International Premenstrual Syndrome Symposium, Los Angeles, CA, June.Google Scholar
  13. Greenstein, B. D., 1978. Evidence of specific progesterone receptors in rat brain Cortisol.Journal of Endocrinology 79: 327–338.PubMedCrossRefGoogle Scholar
  14. Iqbal, M. J. and M. Johnston, 1977. Study of steroid protein binding by a novel “two-tier” column employing ciba-cron blue F3GA Sepharose AB I-sex hormone binding globulin.Journal of Steroid Biochemistry 8: 977–985.PubMedCrossRefGoogle Scholar
  15. Janiger, O., R. Riffenburgh, and R. Kersch, 1972. Cross cultural study of premenstrual symptoms.Psychosomaties 13: 226–235.Google Scholar
  16. Kantero, R. L. and C. Widholm, 1971. The age of menarche in Finnish girls in 1969.Acta Obstetrica and Gynecologica Scandinavica Supplement 14: 7–18.CrossRefGoogle Scholar
  17. Moos, R. H., 1968. The development of a Menstrual Distress Questionnaire.Psychosomatic Medicine 30: 853–867.PubMedGoogle Scholar
  18. Nillius, S. J. and E.D.B. Johansson, 1971. Plasma levels of progesterone after vaginal, rectal or intramuscular administration of progesterone.American Journal of Obstetrics and Gynecology 110: 470–77.PubMedGoogle Scholar
  19. Sampson, G. A. and F. A. Jenner, 1977. Studies of daily recordings from the Moos Menstrual Distress Questionnaire.British Journal of Psychiatry 130: 265–271.PubMedCrossRefGoogle Scholar
  20. Vermeulen, A., 1971. Capacity of testosterone binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate.Journal of Clinical Endocrinology and Metabolism 33:759.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Katharina Dalton
    • 1
  1. 1.University College HospitalLondonEngland

Personalised recommendations